SAO Equity Snapshot

GILD34 Weekly Equity Report

Gilead Sciences, Inc.

Interactive chart JSON snapshot
Latest Close 316.9 BRL 12 Jun 2026
1W Return -5.8% latest completed week
4W Return -3.2% short-term follow-through
12W Return -13.3% quarterly tape
Trend Breadth 78.8% 41 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
Company Brief

What the company does

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment …

Snapshot

What the weekly tape is saying

GILD34 closed the latest completed week at 316.9 BRL. The 4-week return is -3.2% and the 12-week return is -13.3%. Trend Signal is inactive, Market Dynamics is -1.05. Setup signature: Risk-first tape with a 31/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -9.3%
Volume 0.4x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 43 Persistence of active Trend Signal over the last year and current streak.
Momentum 31 Blend of 4-week and 12-week follow-through.
Dynamics 32 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 18 Relative leadership and short-term RS change.
Volume 17 Participation compared with the 13-week volume baseline.
Risk Control 44 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
349.4 BRL
Vs Trend Line
-9.3%
Fair Value
255.8 BRL
Vs Fair Value
23.9%
52W High
394.8 BRL
52W Low
289.9 BRL
Drawdown
-19.7%
Range Position
25.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -5.8%
4W -3.2%
12W -13.3%
26W -4.6%
52W 4.7%

Trend read

Active Streak
0 weeks
52W Active Weeks
41
52W Active Breadth
78.8%
Sector Scope
BR Healthcare
Sector Rank
78 of 80
Sector Percentile
2.5%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
-1.05
4W MD Change
5.9%
Relative Strength
-10.82
4W RS Change
10.0%
Expectation
Undecided
Probability
49.18%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
47
13W Average
117
52W Average
312
Vs 13W
0.4x
Vs 52W
0.2x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
3.1%
52W Volatility
3.4%
Upside Weeks
23
Downside Weeks
25
Downside Breadth
48.1%
Avg Gain / Loss
3.0% / -2.5%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
SAO
Country
BR
Sector
Healthcare
Industry
Drug Manufacturers - General
Currency
BRL
Market Cap
816.1B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Market Dynamics is negative, which weakens the current setup.
  • The latest week was a sharp negative move.
  • Latest weekly return ranks in the weaker part of its sector group.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 316.9 BRL -5.8% 349.4 BRL 255.8 BRL -1.05 -10.82 47 Off
5 Jun 2026 336.3 BRL -1.1% 349.7 BRL 255.0 BRL -1.00 -4.48 23 Off
29 May 2026 340.2 BRL 1.4% 349.4 BRL 253.9 BRL -1.08 -6.26 429 Off
22 May 2026 335.6 BRL 2.6% 348.7 BRL 252.9 BRL -1.15 -9.00 30 Off
15 May 2026 327.2 BRL 2.0% 348.4 BRL 251.9 BRL -1.12 -12.03 259 Off
8 May 2026 320.8 BRL 0.4% 348.5 BRL 251.0 BRL -1.08 -17.08 142 Off
1 May 2026 319.6 BRL -7.1% 348.5 BRL 250.1 BRL -0.92 -18.98 554 Off
24 Apr 2026 344.2 BRL 0.0% 347.6 BRL 249.2 BRL -0.79 -14.65 0 On
17 Apr 2026 344.2 BRL -5.4% 345.9 BRL 248.2 BRL -0.58 -17.06 5 On
10 Apr 2026 363.7 BRL -0.4% 344.4 BRL 247.3 BRL -0.34 -13.49 0 On
3 Apr 2026 365.3 BRL 0.0% 342.4 BRL 246.2 BRL 0.07 -9.24 0 On
27 Mar 2026 365.3 BRL 0.0% 340.4 BRL 245.1 BRL 0.49 -6.43 0 On
20 Mar 2026 365.3 BRL -4.7% 338.3 BRL 244.0 BRL 0.80 -3.93 31 On
13 Mar 2026 383.4 BRL 0.7% 336.4 BRL 242.9 BRL 1.19 -0.13 480 On